Artykuły w czasopismach na temat „Hydrocodone Rescheduling”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Hydrocodone Rescheduling”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Neuman, Mark D., Sean Hennessy, Dylan S. Small, et al. "Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery." Anesthesiology 132, no. 5 (2020): 1151–64. http://dx.doi.org/10.1097/aln.0000000000003188.
Pełny tekst źródłaFernandez, PharmD, BCPS, CGP, Julianna, James Douglas Thornton, PhD, PharmD, BCPS, Sanika Rege, MS, et al. "Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study." Journal of Opioid Management 14, no. 5 (2018): 317–26. http://dx.doi.org/10.5055/jom.2018.0464.
Pełny tekst źródłaLiu, Yingna, Olesya Baker, Jeremiah D. Schuur, and Scott G. Weiner. "Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio." Pain Medicine 21, no. 9 (2019): 1863–70. http://dx.doi.org/10.1093/pm/pnz210.
Pełny tekst źródłaLipman, Arthur. "AMA Fact Sheet on Hydrocodone Rescheduling." Journal of Pain & Palliative Care Pharmacotherapy 29, no. 1 (2015): 82–97. http://dx.doi.org/10.3109/15360288.2014.1003684.
Pełny tekst źródłaYap, Diana. "FDA advisory committee recommends hydrocodone rescheduling." Pharmacy Today 19, no. 3 (2013): 71. http://dx.doi.org/10.1016/s1042-0991(15)31504-8.
Pełny tekst źródła&NA;. "The rescheduling of hydrocodone combination products." Reactions Weekly &NA;, no. 1426 (2012): 5. http://dx.doi.org/10.2165/00128415-201214260-00014.
Pełny tekst źródłaTraynor, Kate. "FDA advisers support rescheduling of hydrocodone products." American Journal of Health-System Pharmacy 70, no. 5 (2013): 382–84. http://dx.doi.org/10.2146/news130017.
Pełny tekst źródłaShumway, MD, John W., Renzhong Ran, MD, Jeff McClusky, BS, Pharm, et al. "Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system." Journal of Opioid Management 14, no. 4 (2018): 257–64. http://dx.doi.org/10.5055/jom.2018.0457.
Pełny tekst źródłaLiaw, Victor, Yong-Fang Kuo, Mukaila A. Raji, and Jacques Baillargeon. "Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation." Public Health Reports 135, no. 1 (2019): 114–23. http://dx.doi.org/10.1177/0033354919892638.
Pełny tekst źródłaSchultz, PharmD, Steven, Carol Chamberlain, PharmD, Psych MA, Marius Vulcan, MD, Humair Rana, MD, Bhavin Patel, PharmD, MBA, and John C. Alexander, MD. "Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center." Journal of Opioid Management 12, no. 2 (2016): 119. http://dx.doi.org/10.5055/jom.2016.0323.
Pełny tekst źródłaCollins, Sonya. "Hydrocodone rescheduling leads to drop in dispensed prescriptions, tablets." Pharmacy Today 22, no. 4 (2016): 41. http://dx.doi.org/10.1016/j.ptdy.2016.03.022.
Pełny tekst źródłaOehler, Elizabeth C., Rachel L. Day, David B. Robinson, and Lawrence H. Brown. "Has the rescheduling of hydrocodone changed ED prescribing practices?" American Journal of Emergency Medicine 34, no. 12 (2016): 2388–91. http://dx.doi.org/10.1016/j.ajem.2016.09.002.
Pełny tekst źródłaShumway, J. W., J. McClusky, W. F. Peacock, A. Cintron, and M. S. Ludwig. "Impact of Rescheduling Hydrocodone Combination Products Among Cancer Patients." International Journal of Radiation Oncology*Biology*Physics 99, no. 2 (2017): E527. http://dx.doi.org/10.1016/j.ijrobp.2017.06.1866.
Pełny tekst źródłaBernhardt, M. Brooke, Ruston S. Taylor, Joseph L. Hagan, et al. "Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products." American Journal of Health-System Pharmacy 74, no. 24 (2017): 2046–53. http://dx.doi.org/10.2146/ajhp160548.
Pełny tekst źródłaHatfield, M. D., S. S. Sansgiry, M. L. Johnson, E. J. Essien, K. H. Todd, and M. L. Fleming. "RESCHEDULING HYDROCODONE COMBINATION PRODUCTS: ASSESSING THE IMPACT ON OPIOID UTILIZATION." Value in Health 19, no. 3 (2016): A255. http://dx.doi.org/10.1016/j.jval.2016.03.1020.
Pełny tekst źródłaFleming, M. L., L. Driver, S. S. Sansgiry, et al. "IMPACT OF HYDROCODONE RESCHEDULING ON TEXAS PHYSICIANS’ FUTURE PAIN MANAGEMENT." Value in Health 19, no. 3 (2016): A258. http://dx.doi.org/10.1016/j.jval.2016.03.1037.
Pełny tekst źródłaRaji, Mukaila A., Yong-Fang Kuo, Deepak Adhikari, Jacques Baillargeon, and James S. Goodwin. "Decline in opioid prescribing after federal rescheduling of hydrocodone products." Pharmacoepidemiology and Drug Safety 27, no. 5 (2017): 513–19. http://dx.doi.org/10.1002/pds.4376.
Pełny tekst źródłaRees, MD, MPH, Chris A., Melanie Brooke Bernhardt, PharmD, Elizabeth A. Camp, PhD, Jessica S. Lin, BA, and Corrie E. Chumpitazi, MD, MS. "Race and ethnicity: Not factors in the prescribing of hydrocodone- and codeine-containing products in two pediatric emergency departments." Journal of Opioid Management 15, no. 3 (2019): 229–33. http://dx.doi.org/10.5055/jom.2019.0506.
Pełny tekst źródłaMattingly II, T. Joseph. "Rescheduling of Combination Hydrocodone Products: Problems for Long-Term Care Practitioners." Consultant Pharmacist 30, no. 1 (2015): 13–17. http://dx.doi.org/10.4140/tcp.n.2015.13.
Pełny tekst źródłaSeago, Susan, Adam Hayek, Jessica Pruszynski, and Megan Greene Newman. "Change in Prescription Habits After Federal Rescheduling of Hydrocodone Combination Products." Baylor University Medical Center Proceedings 29, no. 3 (2016): 268–70. http://dx.doi.org/10.1080/08998280.2016.11929431.
Pełny tekst źródłaFleming, M. L., L. Driver, S. S. Sansgiry, et al. "PREDICTING TEXAS PHYSICIANS’ INTENTION TO PRESCRIBE HYDROCODONE COMBINATION PRODUCTS AFTER RESCHEDULING." Value in Health 19, no. 3 (2016): A258. http://dx.doi.org/10.1016/j.jval.2016.03.1036.
Pełny tekst źródłaOehler, E., R. Day, B. Robinson, and L. Brown. "130 Has the Rescheduling of Hydrocodone Changed Emergency Department Prescribing Practices?" Annals of Emergency Medicine 68, no. 4 (2016): S51. http://dx.doi.org/10.1016/j.annemergmed.2016.08.142.
Pełny tekst źródłaGolembiewski, Julie. "Rescheduling of Hydrocodone Combination Products: Potential Impact and Alternatives for Postoperative Pain Management." Journal of PeriAnesthesia Nursing 30, no. 3 (2015): 244–48. http://dx.doi.org/10.1016/j.jopan.2015.01.005.
Pełny tekst źródłaChumpitazi, Corrie E., Chris A. Rees, Elizabeth A. Camp, and M. Brooke Bernhardt. "Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone." Journal of Emergency Medicine 52, no. 4 (2017): 547–53. http://dx.doi.org/10.1016/j.jemermed.2016.08.026.
Pełny tekst źródłaCovvey, Jordan, Andrea Pfalzgraf, and Peter Cohron. "U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study." Pharmacy 3, no. 3 (2015): 129–36. http://dx.doi.org/10.3390/pharmacy3030129.
Pełny tekst źródłaKuo, Yong‐Fang, Mukaila A. Raji, Victor Liaw, Jacques Baillargeon, and James S. Goodwin. "Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products." Journal of the American Geriatrics Society 66, no. 5 (2018): 945–53. http://dx.doi.org/10.1111/jgs.15332.
Pełny tekst źródłaChambers, Jan, Rae M. Gleason, Kenneth L. Kirsh, et al. "An Online Survey of Patients’ Experiences Since the Rescheduling of Hydrocodone: The First 100 Days." Pain Medicine 17, no. 9 (2015): 1686–93. http://dx.doi.org/10.1093/pm/pnv064.
Pełny tekst źródłaFleming, Marc L., Larry Driver, Sujit S. Sansgiry, et al. "Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach." Research in Social and Administrative Pharmacy 13, no. 3 (2017): 503–12. http://dx.doi.org/10.1016/j.sapharm.2016.07.001.
Pełny tekst źródłaBapat, S., J. D. Thornton, and M. L. Fleming. "PMU49 CHANGES IN ANALGESIC PRESCRIBING AMONG TEXAS ADVANCED PRACTICE PROVIDERS AFTER RESCHEDULING OF HYDROCODONE COMBINATION PRODUCTS." Value in Health 22 (May 2019): S257—S258. http://dx.doi.org/10.1016/j.jval.2019.04.1211.
Pełny tekst źródłaVarisco, Tyler J., Motolani E. Ogunsanya, Jamie C. Barner, and Marc L. Fleming. "Pharmacists’ perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes." Journal of the American Pharmacists Association 57, no. 2 (2017): S51—S62. http://dx.doi.org/10.1016/j.japh.2017.01.020.
Pełny tekst źródłaJones, Christopher M., Peter G. Lurie, and Douglas C. Throckmorton. "Effect of US Drug Enforcement Administration’s Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing." JAMA Internal Medicine 176, no. 3 (2016): 399. http://dx.doi.org/10.1001/jamainternmed.2015.7799.
Pełny tekst źródłaHaider, Ali, Joseph Baidoo, Yee Choon Meng, et al. "Changes in opioid type and dose among cancer patients referred to outpatient palliative care." Journal of Clinical Oncology 34, no. 26_suppl (2016): 106. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.106.
Pełny tekst źródłaFleming, Marc L., Larry Driver, Sujit S. Sansgiry, et al. "Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences." Journal of Pain & Palliative Care Pharmacotherapy 33, no. 1-2 (2019): 22–31. http://dx.doi.org/10.1080/15360288.2019.1615027.
Pełny tekst źródłaWinbigler, Brian L., Michael G. O’Neil, Jeremy Crain, A. Shaun Rowe, and Katherine A. Ryan. "Rescheduling hydrocodone combination products: Impact on patients receiving long-term HCP therapy in a large chain pharmacy—A statewide assessment." Journal of the American Pharmacists Association 60, no. 2 (2020): 374–78. http://dx.doi.org/10.1016/j.japh.2019.10.002.
Pełny tekst źródłaMallama, Celeste, Sara Karami, Di Zhang, et al. "The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures." Pharmacoepidemiology and Drug Safety 33, no. 6 (2024). http://dx.doi.org/10.1002/pds.5793.
Pełny tekst źródłaPergolizzi, JV, F. Breve, R. Taylor, G. Zampogna, and JA LeQuang. "The Aftermath of Hydrocodone Rescheduling: Intentional and Unintended Consequences." January 11, 2017. https://doi.org/10.19070/2332-2780-1600078.
Pełny tekst źródłaYan, C. H., C. C. Hubbard, T. A. Lee, et al. "Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids." JDR Clinical & Translational Research, June 16, 2022, 238008442211028. http://dx.doi.org/10.1177/23800844221102830.
Pełny tekst źródłaJV, Pergolizzi, Breve F, Taylor R, and LeQuang JA. "The Aftermath of Hydrocodone Rescheduling: Intentional and Unintended Consequences." International Journal of Anesthesiology & Research, January 11, 2017, 377–82. http://dx.doi.org/10.19070/2332-2780-1600078.
Pełny tekst źródłaOlvera, Johabed G., Felipe Lozano-Rojas, Julio A. Ramos Pastrana, and Sumedha Gupta. "Opioids Prescribing Restrictions and Homelessness: Evidence from Hydrocodone Rescheduling." Journal of Housing Economics, June 2024, 102010. http://dx.doi.org/10.1016/j.jhe.2024.102010.
Pełny tekst źródłaOlvera, Johabed G., Felipe Lozano-Rojas, Julio Alberto Ramos Pastrana, and Sumedha Gupta. "Opioids Prescribing Restrictions and Homelessness: Evidence from Hydrocodone Rescheduling." SSRN Electronic Journal, 2023. http://dx.doi.org/10.2139/ssrn.4386200.
Pełny tekst źródłaLozano‐Rojas, Felipe, and Mikhail Ivonchyk. "Opioid Epidemic and Local Fiscal Choices: Causal Evidence From Hydrocodone Rescheduling." Public Budgeting & Finance, December 11, 2024. https://doi.org/10.1111/pbaf.12385.
Pełny tekst źródłaUsmani, Silken A., Josef Hollmann, Amie Goodin, et al. "Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review." Journal of the American Pharmacists Association, October 2020. http://dx.doi.org/10.1016/j.japh.2020.09.013.
Pełny tekst źródłaKarami, Sara, Adebola Ajao, Jennie Wong, et al. "The Impact of Hydrocodone Rescheduling on Utilization, Abuse, Misuse, and Overdose Deaths." Pharmacoepidemiology and Drug Safety, February 13, 2023. http://dx.doi.org/10.1002/pds.5603.
Pełny tekst źródłaFischer, Laura J., Stevan G. Severtson, Marie C. Gurrola, Janetta L. Iwanicki, Jody L. Green, and Richard C. Dart. "Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014." Substance Use & Misuse, April 22, 2022, 1–7. http://dx.doi.org/10.1080/10826084.2022.2063898.
Pełny tekst źródłaLozano-Rojas, Felipe. "How Do Local Government Finances Respond to the Opioid Epidemics? Evidence From Hydrocodone Rescheduling." SSRN Electronic Journal, 2020. http://dx.doi.org/10.2139/ssrn.3666448.
Pełny tekst źródłaLozano-Rojas, Felipe, and Amanda J. Abraham. "A Gateway to Misuse? Synthetic Opioid Mortality and the Rescheduling of Hydrocodone in the United States." SSRN Electronic Journal, 2024. https://doi.org/10.2139/ssrn.5044591.
Pełny tekst źródłaWu, Alice, Christine Phan, Kim Chi Nguyen, Melvin Quindoy, Justin Lewis, and Dorie E. Apollonio. "Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling." Clinical Toxicology, August 25, 2020, 1–7. http://dx.doi.org/10.1080/15563650.2020.1803350.
Pełny tekst źródłaWassef, Christina, Alexander Frangenberg, HaEun Lee, et al. "Postoperative emergency department visits for pain after outpatient orthopaedic surgery: did rescheduling hydrocodone make a difference?" Current Orthopaedic Practice Publish Ahead of Print (March 3, 2023). http://dx.doi.org/10.1097/bco.0000000000001201.
Pełny tekst źródła"Fewer hydrocodones prescribed after rescheduling in US." Reactions Weekly 1587, no. 1 (2016): 8. http://dx.doi.org/10.1007/s40278-016-14327-5.
Pełny tekst źródła"Fewer hydrocodones prescribed after rescheduling in US." PharmacoEconomics & Outcomes News 746, no. 1 (2016): 21. http://dx.doi.org/10.1007/s40274-016-2799-5.
Pełny tekst źródła